Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
about
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential RisksThe emerging role of FTY720 (Fingolimod) in cancer treatmentSphingolipids in spinal cord injurySphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentThe emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.Kinase inhibitors as potential agents in the treatment of multiple myeloma.Edge-based sensitivity analysis of signaling networks by using Boolean dynamics.Taming the sphinx: Mechanisms of cellular sphingolipid homeostasis.Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection.NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma.Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.Sphingosine kinase 1 in breast cancer.Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury.The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.Lysophosphatidic Acid Signaling Axis Mediates Ceramide 1-Phosphate-Induced Proliferation of C2C12 Myoblasts.Report of the 12th Sphingolipid Club Meeting, Trabia, Italy (Sept. 7-10, 2017).Targeting Autophagy in ALK-Associated Cancers.Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.The first fluorogenic sensor for sphingosine-1-phosphate lyase activity in intact cells.A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function
P2860
Q26738344-9D7EE625-4332-43A8-8064-E3BFE28205DEQ26748927-5056DFF9-D7C9-414B-BB95-D163823C3078Q27026103-A44ED187-570F-4099-9F28-2FD564921554Q28069459-E70894AF-E9A8-4560-8B9A-07460A18939FQ30252512-21BF312F-D4E6-4278-855B-BB4BDB3B3C51Q33753317-2694BEE6-837A-4A32-B796-808852E483BFQ33829692-A3F821F6-A6B9-4726-A8C6-00EB661785F1Q36413546-02A714CF-3E90-4D94-9E32-7B76343773E1Q36886386-E3066988-9B54-42A5-8513-E3E001F051CAQ37697253-EF86FCA6-B7A1-4249-B85E-A7933967D0DBQ38443092-9842A8D1-2696-4041-AFFE-3B99FF6CAFA7Q38690945-956EB965-7918-4CEB-8FD2-24BED8228328Q38937414-1E1EBD71-404C-430A-956E-C885B038AD5DQ39106107-844AB300-86C5-4A86-95C3-866216770168Q39421907-5AE84549-C342-48D8-818E-61514A215B3CQ40165434-048BE47E-9698-4B30-AD83-8A7745773B73Q41127962-8DF6816A-A0EF-4706-9CD4-4BE3B403F6C2Q41531207-BDD5459A-8652-422D-B536-69D55C4C6FDFQ42120428-361B1A57-CAFC-45B6-AA02-50F423CD8C54Q42348460-1A895F93-9877-4BF3-A22E-50C4509E02B5Q45070648-E2C01109-C0EC-4157-BCCC-D296ED744AA1Q46608425-47C140AC-24FA-4BEC-A5CA-8A66AC9EB03BQ47130227-36653DE8-4EF4-43C0-AEBD-71FF0C0F8670Q47233200-F08CBB98-7C58-484B-A7BF-A11C23ADA120Q48351125-A329F6FF-1455-4200-BE5B-EB330C0AEB75Q49545616-E056640F-E439-4CAE-8215-526FAB82E723Q52592917-06351921-9BCB-4DE8-9496-758DF16ABFFAQ53319527-3D2A1FD5-0D0E-48E0-9E25-7B568F023182Q55001442-FF292E54-6400-4D36-A1E1-5409FA5DFC66Q55002300-6F1AC1DC-B7D9-4DE3-88BA-5F62CDC0D53FQ57486638-C9ACFF06-9D71-4E7E-A348-CB09D3E1A364
P2860
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@ast
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@en
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@nl
type
label
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@ast
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@en
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@nl
prefLabel
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@ast
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@en
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@nl
P2093
P2860
P3181
P1476
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
@en
P2093
Jason Newton
Michael Maceyka
Santiago Lima
P2860
P304
P3181
P356
10.1016/J.YEXCR.2015.02.025
P407
P577
2015-05-01T00:00:00Z